CNBXOTCPharmaceutical PreparationsFiscal year ends August 31
CNBX Pharmaceuticals Inc.
Financials through Q3 FY2026, quarter ended May 31, 2026Last filing: 10-Q on Jun 24, 2026
$0.00+0.00 (0.00%)
Close on Oct 19, 2026
- Market cap
- $197.79K
- P/E (TTM)
- –
- Dividend yield
- –
Dividends
CNBX Pharmaceuticals has not reported a dividend
No dividend per share appears in CNBX Pharmaceuticals's annual filings since fiscal 2010.